The serum concentration of S100A4 in the individuals suffering from HS was significantly elevated when compared to those in the controls (31.57 pg/mL ± 24.38 vs. 22.51 pg/mL ± 23.30, p = 0.022) (Figure 1a). This evidence concerns the gene S100A4 and histiocytic sarcoma.